StoneX Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.63M | Buy |
25,452
+15
| +0.1% | +$1.34K | 0.11% | 157 |
|
|
2026
Q1 | $1.83M | Sell |
25,437
-5,754
| -18% | -$443K | 0.1% | 169 |
|
|
2025
Q4 | $2.48M | Buy |
31,191
+19
| +0.1% | +$1.5K | 0.11% | 153 |
|
|
2025
Q3 | $2.35M | Sell |
31,172
-1,093
| -3% | -$74.9K | 0.1% | 172 |
|
|
2025
Q2 | $2.23M | Buy |
32,265
+1,176
| +4% | +$77.1K | 0.11% | 168 |
|
|
2025
Q1 | $2.11M | Buy |
31,089
+2,483
| +9% | +$149K | 0.12% | 159 |
|
|
2024
Q4 | $1.28M | Sell |
28,606
-13,236
| -32% | -$743K | 0.07% | 239 |
|
|
2024
Q3 | $2.63M | Buy |
41,842
+1,959
| +5% | +$114K | 0.19% | 100 |
|
|
2024
Q2 | $2.36M | Buy |
39,883
+5,954
| +18% | +$372K | 0.19% | 96 |
|
|
2024
Q1 | $2.71M | Buy |
33,929
+6,491
| +24% | +$496K | 0.24% | 88 |
|
|
2023
Q4 | $2.17M | Buy |
27,438
+4,042
| +17% | +$288K | 0.22% | 94 |
|
|
2023
Q3 | $1.63M | Sell |
23,396
-9,757
| -29% | -$691K | 0.18% | 105 |
|
|
2023
Q2 | $2.29M | Buy |
33,153
+13,443
| +68% | +$957K | 0.24% | 86 |
|
|
2023
Q1 | $1.46M | Buy |
19,710
+4,525
| +30% | +$379K | 0.16% | 114 |
|
|
2022
Q4 | $1.42M | Buy |
15,185
+1,884
| +14% | +$182K | 0.17% | 115 |
|
|
2022
Q3 | $1.27M | Sell |
13,301
-1,722
| -11% | -$170K | 0.17% | 116 |
|
|
2022
Q2 | $1.39M | Buy |
15,023
+3,421
| +29% | +$334K | 0.17% | 120 |
|
|
2022
Q1 | $1.17M | Sell |
11,602
-1,499
| -11% | -$157K | 0.09% | 190 |
|
|
2021
Q4 | $1.35M | Buy |
13,101
+1,755
| +15% | +$162K | 0.16% | 136 |
|
|
2021
Q3 | $963K | Sell |
11,346
-1,080
| -9% | -$90.5K | 0.14% | 158 |
|
|
2021
Q2 | $1.04M | Buy |
12,426
+665
| +6% | +$54.5K | 0.15% | 145 |
|
|
2021
Q1 | $885K | Buy |
11,761
+1,099
| +10% | +$80.1K | 0.16% | 134 |
|
|
2020
Q4 | $728K | Buy |
10,662
+2,023
| +23% | +$132K | 0.16% | 135 |
|
|
2020
Q3 | $505K | Buy |
8,639
+264
| +3% | +$16.4K | 0.16% | 148 |
|
|
2020
Q2 | $544K | Buy |
8,375
+1,272
| +18% | +$80.1K | 0.21% | 127 |
|
|
2020
Q1 | $421K | Sell |
7,103
-2,065
| -23% | -$138K | 0.22% | 131 |
|
|
2019
Q4 | $681K | Buy |
9,168
+1,243
| +16% | +$87.3K | 0.28% | 107 |
|
|
2019
Q3 | $500K | Buy |
7,925
+1,135
| +17% | +$67.3K | 0.31% | 113 |
|
|
2019
Q2 | $370K | Buy |
+6,790
| New | +$366K | 0.24% | 132 |
|
|
2017
Q3 | – | Sell |
-40,559
| Closed | -$3.26M | – | 213 |
|
|
2017
Q2 | $3.26M | Buy |
40,559
+29,968
| +283% | +$2.37M | 1.02% | 7 |
|
|
2017
Q1 | $836K | Sell |
10,591
-79
| -0.7% | -$6.31K | 1.87% | 18 |
|
|
2016
Q4 | $842K | Buy |
+10,670
| New | +$863K | 1.47% | 22 |
|
Other funds holding CVS
StoneX Group's CVS Position: Q2 2026 in Review
StoneX Group increased its CVS Health (CVS) stake by 0.06% in Q2 2026, buying an estimated $1.34K and bringing the position to 25,452 shares worth $2.63M. The position accounts for 0.11% of the portfolio, ranked #157.
StoneX Group first reported a position in CVS in Q4 2016 and has held it in 32 quarters since. The position peaked at $3.26M in Q2 2017. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- StoneX Group held 25,452 shares of CVS Health worth $2.63M as of Q2 2026.
- StoneX Group bought 15 CVS Health shares in Q2 2026, an estimated $1.34K.
- CVS Health made up 0.11% of StoneX Group's portfolio in Q2 2026, its #157 holding.
- StoneX Group first reported a position in CVS Health in Q4 2016 and has held it in 32 quarters since.
- StoneX Group's CVS Health position peaked at $3.26M in Q2 2017.
- 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.